Association of different lipid measures with incident bone fractures: Tehran lipid and glucose study

References

• Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359(9319):1761–1767.
   PubMed Web of Science ®Google Scholar
• Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global burden of disease study 2016. Lancet. 2017;390(10100):1260–1344.
   PubMed Web of Science ®Google Scholar
• Ahmadi-Abhari S, Moayyeri A, Abolhassani F. Burden of hip fracture in Iran. Calcif Tissue Int. 2007;80(3):147–153.
   PubMed Web of Science ®Google Scholar
• Hadaegh F, Asgari S, Toreyhi H, et al. Sex-specific incidence rates and risk factors for fracture: a 16-year follow-up from the Tehran lipid and glucose study. Bone. 2021;146:115869.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Odén A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155–162.
   PubMed Web of Science ®Google Scholar
• Sadeghi O, Saneei P, Nasiri M, et al. Abdominal obesity and risk of hip fracture: a systematic review and meta-analysis of prospective studies. Adv Nutr. 2017;8(5):728–738.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, et al. A meta‐analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19(6):893–899.
   PubMed Web of Science ®Google Scholar
• Chang P-Y, Gold EB, Cauley JA, et al. Triglyceride levels and fracture risk in midlife women: study of women’s health across the nation (SWAN). J Clin Endocrinol Metab. 2016;101(9):3297–3305.
   PubMed Web of Science ®Google Scholar
• Fan Y, Wei F, Lang Y, et al. Diabetes mellitus and risk of hip fractures: a meta-analysis. Osteoporos Int. 2016;27(1):219–228.
   PubMed Web of Science ®Google Scholar
• Li C, Zeng Y, Tao L, et al. Meta-analysis of hypertension and osteoporotic fracture risk in women and men. Osteoporos Int. 2017;28(8):2309–2318.
   PubMed Web of Science ®Google Scholar
• Ge G, Li J, Wang Q. Heart failure and fracture risk: a meta-analysis. Osteoporos Int. 2019;30(10):1903–1909.
   PubMed Web of Science ®Google Scholar
• Tohidi M, Hatami M, Hadaegh F, et al. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in middle eastern women. J Hum Hypertens. 2012;26(9):525–532.
   PubMed Web of Science ®Google Scholar
• Sardarinia M, Akbarpour S, Lotfaliany M, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a middle eastern population over a decade follow-up: Tehran lipid and glucose study. PloS one. 2016;11(12):e0167623.
   PubMed Web of Science ®Google Scholar
• Hadaegh F, Hatami M, Tohidi M, et al. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis. 2010;9(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ghorabi S, Shab-Bidar S, Sadeghi O, et al. Lipid profile and risk of bone fracture: a systematic review and meta-analysis of observational studies. Endocr Res. 2019;44(4):168–184.
   PubMed Web of Science ®Google Scholar
• Amouzegar A, Asgari S, Azizi F, et al. The role of metabolic syndrome and its components in incident fracture: a 15-year follow-up among the Iranian population. J Clin Endocrinol Metab. 2021;106(5):e1968–e1983.
   PubMed Web of Science ®Google Scholar
• Aryan Z, Mahmoudi N, Sheidaei A, et al. The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: surveillance of risk factors of noncommunicable diseases in Iran 2016. J Clin Lipidol. 2018;12(6):1471–1481. e4.
   PubMed Web of Science ®Google Scholar
• Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):1–15.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang X, Pan B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010;9(1):1–5.
   PubMed Web of Science ®Google Scholar
• Kheirandish M, Asgari S, Lotfaliany M, et al. Secular trends in serum lipid levels of a middle eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13(1):1–13.
   PubMed Web of Science ®Google Scholar
• Hadaegh F, Harati H, Ghanbarian A, et al. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study. Eur J Prev Cardiol. 2006;13(4):571–577.
   Web of Science ®Google Scholar
• Schuit S, Van der Klift M, Weel A, et al. Fracture incidence and association with bone mineral density in elderly men and women: the rotterdam study. Bone. 2004;34(1):195–202.
   PubMed Web of Science ®Google Scholar
• Trajanoska K, Schoufour JD, de Jonge EA, et al. Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: the rotterdam study. Bone. 2018;114:116–124.
   PubMed Web of Science ®Google Scholar
• Dominic E, Brozek W, Peter RS, et al. Metabolic factors and hip fracture risk in a large Austrian cohort study. Bone Rep. 2020;12:100244.
   PubMedGoogle Scholar
• Ahmed LA, Schirmer H, Berntsen GK, et al. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int. 2006;17(3):426–432.
   PubMed Web of Science ®Google Scholar
• Szulc P, Varennes A, Delmas PD, et al. Men with metabolic syndrome have lower bone mineral density but lower fracture risk—the MINOS study. J Bone Miner Res. 2010;25(6):1446–1454.
   PubMed Web of Science ®Google Scholar
• Lee SH, Baek S, Ahn SH, et al. Association between metabolic syndrome and incident fractures in Korean men: a 3-year follow-up observational study using national health insurance claims data. J Clin Endocrinol Metab. 2014;99(5):1615–1622.
   PubMed Web of Science ®Google Scholar
• Gregson C, Dennison EM, Compston JE, et al. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int. 2014;25(1):85–95.
   PubMed Web of Science ®Google Scholar
• Chin K-Y, Wong SK, Ekeuku SO, et al. Relationship between metabolic syndrome and bone health–an evaluation of epidemiological studies and mechanisms involved. Diabetes Metab Syndr Obes. 2020;13:3667.
   PubMed Web of Science ®Google Scholar
• Wong SK, Chin K-Y, Suhaimi FH, et al. The relationship between metabolic syndrome and osteoporosis: a review. Nutrients. 2016;8(6):347.
   PubMed Web of Science ®Google Scholar
• Lidfeldt J, Holmdahl L, Nerbrand C, et al. The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women’s health in the lund area study. Metab Clin Exp. 2002;51(2):267–270.
   PubMed Web of Science ®Google Scholar
• Brownbill R, Ilich J. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Women’s Health. 2006;15(3):261–270.
   PubMed Web of Science ®Google Scholar
• Xu S, Jianqing JY. Beneath the minerals, a layer of round lipid particles was identified to mediate collagen calcification in compact bone formation. Biophys J. 2006;91(11):4221–4229.
   PubMed Web of Science ®Google Scholar
• Adami S, Braga V, Zamboni M, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int. 2004;74(2):136–142.
   PubMed Web of Science ®Google Scholar
• Vatandost S, Jahani M, Afshari A, et al. Prevalence of vitamin D deficiency in Iran: a systematic review and meta-analysis. Nutr Health. 2018;24(4):269–278.
   PubMedGoogle Scholar
• Saei Ghare Naz M, Sayehmiri F, Kiani F, et al. A systematic review and meta-analysis on the average age of menopause among Iranian women. Evidence Based Care. 2019;8(4):26–34.
   Google Scholar